Skip to content

Comparison of the Postoperative Analgesic Effects of ITM and Bi-level ESPB in Liver Transplantation Donors

Comparison of the Postoperative Analgesic Effects of Intrathecal Morphine and Bi-level Erector Spinae Plane Block in Liver Transplantation Donors

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07123740
Enrollment
60
Registered
2025-08-14
Start date
2025-08-18
Completion date
2026-07-24
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplantation, Pain Management

Keywords

Liver Transplantation, Intrathecal Morphine, Erector Spinae Plane Block

Brief summary

Liver transplantation is a life-saving procedure for patients with end-stage liver disease, and postoperative pain management is critical for optimizing donor recovery and overall outcomes. Poorly controlled pain following donor hepatectomy may reduce quality of life, delay mobilization, and contribute to the development of chronic pain syndromes. Regional anesthesia techniques, such as intrathecal morphine and erector spinae plane block, have been utilized to enhance postoperative analgesia and reduce perioperative opioid requirements, potentially minimizing opioid-related adverse effects. In this study, we aimed to compare the postoperative analgesic efficacy of intrathecal morphine and Bi-level erector spinae plane block in living liver donors.

Interventions

PROCEDUREIntrathecal Morphine

An intrathecal injection of morphine 300μg will be administered at the L3-L4 or L4-L5 level. Additionally, in the postoperative period a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.

Bi-level erector spinae plane block will be performed on the patients using a total of 40 ml of 0.25% bupivacaine under ultrasound guidance. Additionally, in the postoperative period a dexketoprofen dose of 50 mg twice daily were administered iv for multimodal analgesia.

Sponsors

Ankara Etlik City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18-65 years * American Society of Anesthesiologists (ASA) score I-II * Body Mass Index (BMI) between 18-30 kg/m2

Exclusion criteria

* Patients under 18 and over 65 years of age * ASA score III and above * Patients with a history of bleeding diathesis * BMI below 18 or above 30 kg/m2

Design outcomes

Primary

MeasureTime frameDescription
Pain ScoresOn the operation dayPain will be assessed at rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 10 (worst pain). Pain assessment will be done at 0st, 1st, 2nd,4th, 12th, and 24th hours after surgery.

Secondary

MeasureTime frameDescription
Intraoperative opioid consumptionIntraoperative periodRemifentanil consumption for intraoperative period will be recorded
Postoperative Opioid ConsumptionOn the operation dayOpioid consumption for 24 hours will be recorded

Countries

Turkey (Türkiye)

Contacts

Primary ContactAtakan Sezgi
kansezgi@gmail.com00905323327000
Backup ContactJülide Ergil
julideergil@hotmail.com00905323469216

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026